World’s top humanoid robot maker surges in blockbuster market debut in China

Unitree’s Shanghai Debut Sends Shockwaves Through Global Robotics Markets

Healfromzero.com – The trading floor in Shanghai witnessed something unprecedented on Wednesday: shares of a humanoid robot manufacturer soared past 600 percent on their first day of exchange listing. Unitree, the Hangzhou-based firm that has become synonymous with China’s push into bipedal robotics, completed an initial public offering that raised 6.1 billion yuan (approximately $905 million). Demand for the shares exceeded supply by more than 8,000 times, setting a new record on the STAR Market — the tech-oriented board of Shanghai’s stock exchange that analysts frequently compare to the Nasdaq in the United States.

The listing marks a first: Unitree is the initial humanoid robot company to be publicly traded on mainland China’s exchanges. Rival firms such as UBTECH and Dobot have already listed in Hong Kong, while Agibot, another leading name in the sector, is actively pursuing its own IPO on the island’s markets. The distinction matters because a mainland listing signals deeper integration with domestic capital flows and state-backed industrial policy.

A Robot That Jumps Two Metres

Just days before the bell rang, Unitree introduced a new humanoid platform it has branded “Superman.” The machine can leap to a height of two metres and sprint at 12.66 metres per second — figures that place it among the fastest bipedal platforms ever demonstrated by a commercial firm. The unveiling on Monday added fresh momentum to an already feverish trading week.

Unitree first captured the public imagination last year when its androids performed choreographed dance routines on the stage of China’s annual Lunar New Year gala, the country’s most-watched television event. Clips of the robots executing backflips and synchronized movements spread across social media within hours, and the company’s name became a household reference point for Chinese consumers who had previously associated humanoid robotics with laboratory prototypes.

Beijing’s Strategic Wager

The company’s ascent tracks a deliberate national strategy. As China’s economic expansion moderates and its working-age population contracts, the government has poured billions of dollars into humanoid robotics, viewing the category as the next disruptive product class. A 2023 policy document described humanoid robots as the “new high ground of technological competition and a fresh frontier for future industries,” language that has since been echoed in provincial investment plans and university curriculum reforms.

Founder Wang Xingxing’s presence in the front row at President Xi Jinping’s rare symposium with leading technology firms last year underscored how closely the company is woven into the state’s industrial agenda. Outperforming in this sector would also strengthen China’s position in the intensifying technology rivalry with the United States, where firms such as Tesla, Figure AI, and Boston Dynamics are racing to deploy their own bipedal platforms.

Financial Trajectory and Investor Caution

Unitree’s prospectus reveals a company that has scaled rapidly. Revenue multiplied more than tenfold over two years, reaching nearly 1.7 billion yuan ($252 million) in 2025. The firm posted a net profit of 278 million yuan ($41 million) last year, making it one of the very few players in the humanoid space that has reached profitability. It delivered over 5,500 humanoid units worldwide in the past twelve months, cementing its position as the largest seller of androids by volume.

Quadruped machines — commonly called robot dogs — still contributed roughly 42 percent of revenue last year, indicating that the humanoid line, while growing fast, has not yet displaced the company’s earlier product category.

Investors and analysts, however, urge patience. Ethan Qi, associate director at market analysis firm Counterpoint Research, framed the listing in broader industry terms:

“Unitree IPO is regarded as a key milestone for the humanoid industry and can serve as a benchmark for other IPOs in the pipeline.”

Qi also cautioned that Unitree’s competitive advantage appears concentrated in hardware engineering and motion control, and that the firm must substantially increase investment in embodied AI models — the software layer that functions as the machine’s cognitive core.

Kangyuxiao Li, an equity analyst at financial services firm Morningstar, offered a complementary perspective on the gap between spectacle and deployment:

“Unitree has demonstrated strong technology and commercial traction, but moving from demonstrations and early deployments to widespread industrial adoption will take time.”

The company’s own filing confirms the point. In the first three quarters of 2025, research institutions and educational buyers accounted for the bulk of Unitree’s humanoid sales, while industrial deployments represented less than ten percent of unit volume. Factory-floor and household use remain years away, experts note, given unresolved constraints in both mechanical reliability and autonomous decision-making.

Backers, Origins, and What Comes Next

Founded in 2016 in Hangzhou — China’s eastern technology corridor alongside Shenzhen and Beijing — Unitree has attracted equity from a constellation of major domestic firms: food-delivery platform Meituan, internet giant Tencent, e-commerce and cloud conglomerate Alibaba, and AI startup DeepSeek. That investor roster provides both capital access and distribution channels across consumer, commercial, and industrial verticals.

Proceeds from the IPO, as outlined in the prospectus, will fund research and development of embodied AI models, next-generation robot hardware, and expansion of manufacturing capacity. The company’s stated ambition is to close the gap between the impressive physical capabilities already demonstrated and the reliable, general-purpose autonomy that would make humanoid robots economically viable at scale.

For now, the market has spoken with extraordinary enthusiasm. Whether that enthusiasm translates into sustained industrial adoption — rather than a cycle of viral demonstrations followed by quiet shelving — remains the central question facing Unitree, its investors, and the broader Chinese robotics ecosystem as it steps onto the world stage.